Simon Husby
Senior Researcher
Grønbæk Group
Ole Maaløes Vej 5
2200 København N.
1 - 4 out of 4Page size: 10
- 2023
- Published
CD3xCD20 Bispecific Antibodies Yields Long-Term Survival in Relapsed/Refractory B Cell Lymphoma: A Follow-up Study of Patients Treated in Pivotal Phase 1/2 Trials
Kyvsgaard, Emil Ramsø, Clausen, M. R., Hasselbalch Riley, A. C., Niemann, Carsten, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 618-618Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunohistochemical Tumor Expression Predicts Response to CD3xCD20 Bispecific Antibodies in Patients with Relapsed/Refractory B Cell Lymphoma
Kyvsgaard, Emil Ramsø, Clausen, M. R., Hasselbalch Riley, A. C., Niemann, Carsten, Sjö, Lene Dissing, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 6113-6113Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score
Salim, Ruth, Husby, Simon, Winther Eskelund, C., Scott, D. W., Holte, H., Kolstad, A., Räty, R., Ek, S., Jerkeman, M., Geisler, C., Sommer Kristensen, L., Dahl, M. & Grønbæk, Kirsten, 2023, In: Leukemia and Lymphoma. 64, 8, p. 1414-1423Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established high-risk factors
Gerdtsson, A. S., de Matos Rodrigues, J., Eskelund, C. W., Husby, Simon, Grønbæk, Kirsten, Räty, R., Kolstad, A., Geisler, C., Porwit, A., Jerkeman, M. & Ek, S., 2023, In: Haematologica. 108, 4, p. 1092-1104 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 19204297